NELEEN BONILLA: Open Payments
NPI 1760879738 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 6 payments from 4 companies in 2025. Trend: 2023 $261 · 2024 $1,047 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $388 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $246 |
| SCPHARMACEUTICALS INC. | 1 | $127 |
| TriSalus Life Sciences, Inc. | 1 | $25 |
Products named: WAINUA, FUROSCIX, JARDIANCE, LOKELMA, TRINAV INFUSION SYSTEM.
Industry payments across MD — which companies pay providers there.
